Kovacs Shane William Charles
SEC CIK 1579397 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OLMA | Olema Pharmaceuticals, Inc. | Ch. Operating, Financial Off | 139.7K | — | $3.57M | 12 | 2022-09-02 | 2026-01-13 |
Most active insiders at OLMA, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | CLARK IAN T | Dir | — | $7.87M |
| 2 | Zojwalla Naseem | Chief Medical Off | — | $7.53M |
| 3 | Myles David C. | CH. DISCOV, NON-CLIN DEV OFF | — | $4.66M |
| 4 | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | — | $2.98M |
| 5 | Mitchell Shawnte | CLO | — | $951.5K |
| 6 | Harmon Cyrus | Dir | — | $743.8K |
| 7 | Austin Sasha Lu | VP of Fin, Ctrl | — | — |
| 8 | Bohen Sean | Pres, CEO, Dir | — | — |
| 9 | RAPPAPORT ANDREW | Dir | — | — |
Transactions 12
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| M | 2026-01-15 | 2026-01-13+ | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | S - Sale | $28.70 | -103.8K | 139.7K | -43% | -$2.98M |
| 2025-12-09 | 2025-12-08 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | G - Gift | $0.00 | -75.0K | 243.5K | -24% | $0 | |
| 2025-12-01 | 2025-11-26 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | G - Gift | $0.00 | -225.0K | 318.5K | -41% | $0 | |
| M | 2024-12-11 | 2024-12-10+ | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | S - Sale | $9.01 | -35.2K | 543.5K | -6% | -$316.7K |
| 2024-12-11 | 2024-12-09 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | A - Grant | $0.00 | +68.2K | 578.7K | +13% | $0 | |
| D | 2024-11-18 | 2024-11-15 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | Ch. Operating, Financial Off | M - OptEx | $7.02 | +25.0K | 510.5K | +5% | +$175.5K |
| D | 2024-01-16 | 2024-01-12 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | M - OptEx | $7.02 | +50.0K | 485.0K | +11% | +$351.0K |
| D | 2023-12-12 | 2023-12-12 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | M - OptEx | $7.02 | +10.0K | 435.0K | +2% | +$70.2K |
| M | 2023-11-22 | 2023-11-21+ | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | S - Sale | $14.39 | -18.7K | 434.8K | -4% | -$269.7K |
| 2023-11-22 | 2023-11-20 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | A - Grant | $0.00 | +36.8K | 443.7K | +9% | $0 | |
| 2023-04-07 | 2023-04-06 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | P - Purchase | — | +10.0K | 396.2K | +3% | — | |
| 2022-09-06 | 2022-09-02 | OLMA | Olema Pharmaceuticals, Inc. | Kovacs Shane William Charles | CH. OPERATING, FINANCIAL OFF | P - Purchase | — | +20.0K | 381.2K | +6% | — |
Purchase Sale Sale after option exercise All abbreviations